Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Ozempic and Wegovy are once-weekly injectable weight loss medications now approved by the FDA for the long-term treatment of diabetes and obesity
Switching from tirzepatide to retatrutide The safest approach based on current clinical understanding: Stop tirzepatide and allow a washout period of 1-2 weeks (tirzepatide half-life is approximately 5 days) Start retatrutide at 2 mg regardless of your previous tirzepatide dose Titrate up on the standard schedule , every 4 weeks Do not skip steps because you were on high-dose tirzepatide, the glucagon receptor is new territory for your body The rationale is straightforward
Then, gently swirl or roll the vial between your palms until the powder is fully dissolved
elderly patients have increased risk
Do NOT take if you have: Our medical team reviews your health history to ensure safety
Test conducted by an independent laboratory on 20 volunteers, aged 30-60 years
